Rapid2 Therapy System

Transcranial Magnetic Stimulator

MAGSTIM COMPANY LTD.

The following data is part of a premarket notification filed by Magstim Company Ltd. with the FDA for Rapid2 Therapy System.

Pre-market Notification Details

Device IDK162935
510k NumberK162935
Device Name:Rapid2 Therapy System
ClassificationTranscranial Magnetic Stimulator
Applicant MAGSTIM COMPANY LTD. SPRING GARDENS Whitland,  GB Sa34 0hr
ContactKevyn Beard
CorrespondentKevyn Beard
MAGSTIM COMPANY LTD. SPRING GARDENS Whitland,  GB Sa34 0hr
Product CodeOBP  
CFR Regulation Number882.5805 [🔎]
DecisionSubstantially Equivalent (SESE)
TypeTraditional
3rd Party ReviewedNo
Combination ProductNo
Date Received2016-10-20
Decision Date2017-03-10
Summary:summary

NIH GUDID Devices

Device IdentifiersubmissionNumberSupplement
05060229532169 K162935 000

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.